Invesco SteelPath业主有限合伙与能源设备主动型ETF PIPE 深 沪
已收盘 03-27 16:00:00 美东时间
29.8579
-0.036
-0.12%
华盛通- 最 高29.8579
- 今 开30.20
- 成交量 169股
- 最 低 29.8579
- 昨 收 29.8943
- 总市值 6150.73万
- 52周最高 29.96
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 19.9815
- 委 比 0.00%
- 总股本 206.00万
- 历史最高 29.96
- 量 比 0.19
- 振 幅 0.00%
- 历史最低 19.9815
- 每 手 1
- 风险率 1.91%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Senti Biosciences Q4 revenue misses analyst estimates
Senti Biosciences Q4 revenue misses analyst estimates Overview US biotech firm's Q4 revenue missed analyst expectations Adjusted EPS for Q4 was a loss Company reported positive preliminary clinical data for SENTI-202 and received RMAT designation Outlook Company did not provide specific financial gu
03-27 20:11
Pulmatrix Signs Agreement To Acquire Eos SENOLYTIX; Financial Terms Undisclosed
Pulmatrix, Inc. (Nasdaq: PULM) ("Pulmatrix") and Eos SENOLYTIX, Inc. ("Eos"), a biotechnology company developing novel gerotherapeutic peptides targeting mitochondrial dysfunction in aging-related diseases, today jointly
03-26 20:03
Acumen Pharma posts smaller-than-expected 2025 loss on lower G&A costs
Acumen Pharma posts smaller-than-expected 2025 loss on lower G&A costs Overview U.S. Alzheimer's drug developer's 2025 net loss and operating loss both narrower than analyst estimates R&D expenses rose on higher costs for ALTITUDE-AD trial and pipeline expansion Company raised $35.75 mln in March 20
03-26 19:10
Health In Tech announces $7M private placement
Health In Tech (HIT) has entered into a securities purchase agreement for a private investment in public equity financing that is expected to result in gross proceeds of ~$7.0. Health In Tech will iss...
03-26 05:46
Health In Tech Reveals $7.0M Private Placement
Health In Tech, Inc. (NASDAQ:HIT) ("Health In Tech" or the "Company"), an AI-enabled InsurTech platform company, today announced that it has entered into a securities purchase agreement for a private investment in public
03-26 05:41
BRIEF-Sarepta Announces First Clinical Data From Sirna Pipeline Targeting Fshd1 And Dm1
BRIEF-Sarepta Announces First Clinical Data From Sirna Pipeline Targeting Fshd1 And Dm1 Sarepta Therapeutics Inc SRPT.O : SAREPTA ANNOUNCES FIRST CLINICAL DATA FROM SIRNA PIPELINE TARGETING FSHD1 AND DM1 SAREPTA THERAPEUTICS INC - SIRNA ACHIEVES HIGH MUSCLE CONCENTRATIONS WITHOUT DOSE LIMITING TOXIC
03-25 20:29
BRIEF-Nov Inc Announces $200 Million Capital Expansion For Offshore And High-Co₂ Solutions
BRIEF-Nov Inc Announces $200 Million Capital Expansion For Offshore And High-Co₂ Solutions March 25 (Reuters) - Nov Inc NOV.N : NOV INC - PLANS TO ROUGHLY DOUBLE CAPACITY OF ITS SUBSEA FLEXIBLE PIPE MANUFACTURING FACILITY IN AÇU, BRAZIL OVER NEXT THREE YEARS (ADDS DROPPED SOURCE) NOV INC - ANNOUNCES
03-25 18:38
BRIEF-Merck Nears $6Bn Biotech Deal To Boost Cancer Drug Pipeline - Ft
BRIEF-Merck Nears $6Bn Biotech Deal To Boost Cancer Drug Pipeline - Ft March 24 (Reuters) - FINANCIAL TIMES: MERCK NEARS $6BN BIOTECH DEAL TO BOOST CANCER DRUG PIPELINE - FT MERCK'S ALL-CASH DEAL IS EXPECTED TO VALUE TERNS AT ROUGHLY $6BN - FT TALKS BETWEEN MERCK AND TERNS WERE AT AN ADVANCED STAGE
03-25 09:03
Horizon Space Acquisition II Announces PIPE Financing Deal
Horizon Space Acquisition II Corp. ( ($HSPT) ) has shared an update. On May 9, ...
03-25 04:58
Alchemy, Cartiga Explore PIPE Financing for Proposed Merger
An announcement from Alchemy Investments Acquisition Corp 1 Class A ( ($ALCY) )...
03-25 04:54
